Literature DB >> 26543619

Clinical manifestations of sleep apnea.

Robert C Stansbury1, Patrick J Strollo1.   

Abstract

Obstructive sleep apnea (OSA) may manifest in a number of ways from subtle intrusion into daily life to profound sleepiness, snoring, witnessed apneas and other classic symptoms. Although there is increasing evidence suggesting OSA can adversely affect health in a variety of ways, this disorder remains underdiagnosed. The most well-escribed health consequences of OSA relate to the cardiovascular system. Hypertension and arrhythmias have a strong association with OSA, and evidence suggests that treatment of OSA in patients with refractory hypertension and in patients planning cardioversion for atrial fibrillation may be of particularly importance. Significant associations between heart failure and OSA as well as complex sleep apnea have also been well-described. Cerebrovascular insult, impaired neurocognition, and poorly controlled mood disorder are also associated with in OSA. Therapy for OSA may ameliorate atherosclerotic progression and improve outcomes post-cerebrovascular accident (CVA). OSA should be considered in patients complaining of poor concentration at work, actual or near-miss motor vehicle accidents, and patients with severe sleepiness as a component of their co-morbid mood disorders. The metabolic impact of OSA has also been studied, particularly in relation to glucose homeostasis. Also of interest is the potential impact OSA has on lipid metabolism. The adverse effect untreated OSA has on glucose tolerance and lipid levels has led to the suggestion that OSA is yet another constituent of the metabolic syndrome. Some of these metabolic derangements may be related to the adverse effects untreated OSA has on hepatic health. The cardiovascular, neurocognitive, and metabolic manifestations of OSA can have a significant impact on patient health and quality of life. In many instances, evidence exists that therapy not only improves outcomes in general, but also modifies the severity of co-morbid disease. To mitigate the long-term sequela of this disease, providers should be aware of the subtle manifestations of OSA and order appropriate testing as necessary.

Entities:  

Keywords:  Obstructive sleep apnea (OSA); cardiovascular consequences of sleep apnea; metabolic derangements in sleep apnea; neurocognitive impact of sleep apnea

Year:  2015        PMID: 26543619      PMCID: PMC4598518          DOI: 10.3978/j.issn.2072-1439.2015.09.13

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  87 in total

1.  Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study.

Authors:  Susan Redline; Gayane Yenokyan; Daniel J Gottlieb; Eyal Shahar; George T O'Connor; Helaine E Resnick; Marie Diener-West; Mark H Sanders; Philip A Wolf; Estella M Geraghty; Tauqeer Ali; Michael Lebowitz; Naresh M Punjabi
Journal:  Am J Respir Crit Care Med       Date:  2010-03-25       Impact factor: 21.405

Review 2.  Sleep apnea and cardiovascular disease: a bidirectional relationship.

Authors:  Takatoshi Kasai; John S Floras; T Douglas Bradley
Journal:  Circulation       Date:  2012-09-18       Impact factor: 29.690

3.  High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.

Authors:  A G Logan; S M Perlikowski; A Mente; A Tisler; R Tkacova; M Niroumand; R S Leung; T D Bradley
Journal:  J Hypertens       Date:  2001-12       Impact factor: 4.844

4.  Pulmonary arterial hypertension in patients with sleep apnoea syndrome.

Authors:  E Bady; A Achkar; S Pascal; E Orvoen-Frija; J P Laaban
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

Review 5.  Obstructive sleep apnea and hypertension: a critical review.

Authors:  Vahid Mohsenin
Journal:  Curr Hypertens Rep       Date:  2014-10       Impact factor: 5.369

6.  Association of sleep apnea and type II diabetes: a population-based study.

Authors:  Kevin J Reichmuth; Diane Austin; James B Skatrud; Terry Young
Journal:  Am J Respir Crit Care Med       Date:  2005-09-28       Impact factor: 21.405

7.  Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.

Authors:  Monique N Pratt-Ubunama; Mari K Nishizaka; Robyn L Boedefeld; Stacey S Cofield; Susan M Harding; David A Calhoun
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

Review 8.  Disorders of glucose metabolism in sleep apnea.

Authors:  Naresh M Punjabi; Vsevolod Y Polotsky
Journal:  J Appl Physiol (1985)       Date:  2005-11

9.  Diabetes and sleep disturbances: findings from the Sleep Heart Health Study.

Authors:  Helaine E Resnick; Susan Redline; Eyal Shahar; Adele Gilpin; Anne Newman; Robert Walter; Gordon A Ewy; Barbara V Howard; Naresh M Punjabi
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

10.  Obstructive sleep apnea and the recurrence of atrial fibrillation.

Authors:  Ravi Kanagala; Narayana S Murali; Paul A Friedman; Naser M Ammash; Bernard J Gersh; Karla V Ballman; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

View more
  26 in total

1.  Interfacing pathophysiology of respiratory sleep disorders, cardiac dysfunction, and focal autonomic medullary brain ischemia.

Authors:  J Howard Jaster
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

2.  Hospital screening for obstructive sleep apnea in patients admitted to a rural, tertiary care academic hospital with heart failure.

Authors:  Robert Stansbury; Mohamad Abdelfattah; Jonathan Chan; Abhinav Mittal; Fahad Alqahtani; Sunil Sharma
Journal:  Hosp Pract (1995)       Date:  2020-08-04

Review 3.  Autophagy and inflammation in chronic respiratory disease.

Authors:  Alexandra C Racanelli; Sarah Ann Kikkers; Augustine M K Choi; Suzanne M Cloonan
Journal:  Autophagy       Date:  2018-02-08       Impact factor: 16.016

4.  Which Screening Questionnaire is Best for Predicting Obstructive Sleep Apnea in the Sleep Clinic Population Considering Age, Gender, and Comorbidities?

Authors:  Burcu Oktay Arslan; Zeynep Zeren Uçar Hoşgör; Mehmet Nurullah Orman
Journal:  Turk Thorac J       Date:  2020-11-01

5.  Reduced Peripheral Blood Mononuclear Cell ROCK1 and ROCK2 Levels in Obstructive Sleep Apnea Syndrome.

Authors:  Şenay Aydin; Cengiz Özdemir; Cem Ismail Küçükali; Sinem Nedime Sökücü; Murat Giriş; Uğur Akcan; Erdem Tüzün
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

6.  Does experimental paradoxical sleep deprivation (EPSD) is an appropriate model for evaluation of cardiovascular complications of obstructive sleep apnea?

Authors:  Siyavash Joukar; Soodabe Ghorbani-Shahrbabaki
Journal:  Sleep Breath       Date:  2015-12-30       Impact factor: 2.816

7.  Effects of continuous positive airway pressure and isocapnic-hypoxia on cerebral autoregulation in patients with obstructive sleep apnoea.

Authors:  Xavier Waltz; Andrew E Beaudin; Patrick J Hanly; Georgios D Mitsis; Marc J Poulin
Journal:  J Physiol       Date:  2016-12-01       Impact factor: 5.182

8.  Inpatient CPAP adherence may predict post-discharge adherence in hospitalized patients screened high risk for OSA.

Authors:  Sunil Sharma; Robert Stansbury; Varun Badami; Edward Rojas; Stuart F Quan
Journal:  Sleep Breath       Date:  2022-06-18       Impact factor: 2.816

9.  Underrecognition of sleep-disordered breathing and other common health conditions in the West Virginia Medicaid population: a driver of poor health outcomes.

Authors:  Robert Stansbury; Patrick Strollo; Nathan Pauly; Ira Sharma; Marco Schaaf; Anina Aaron; Judith Feinberg
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.062

10.  Parametric Analysis of an Integrated Model of Cardio-respiratory Interactions in Adults in the Context of Obstructive Sleep Apnea.

Authors:  Gustavo Guerrero; Virginie Le Rolle; Alfredo Hernández
Journal:  Ann Biomed Eng       Date:  2021-08-31       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.